Montag A & Associates Inc Pfizer Inc Transaction History

Montag A & Associates Inc

$2.09 Billion
Q3 2024

A detailed history of Montag A & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Montag A & Associates Inc holds 80,472 shares of PFE stock, worth $2.12 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

80,472

Previous 81,151 0.84%

Holding current value

$2.12 Million

Previous $2.27 Million 2.56%

% of portfolio

0.11%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $18,808 - $21,313	-679 Reduced 0.84%	80,472 $2.33 Million
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $193,011 - $226,173	-7,641 Reduced 8.61%	81,151 $2.27 Million
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $620,764 - $712,836	-23,977 Reduced 21.26%	88,792 $2.46 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $63,495 - $82,474	-2,430 Reduced 2.11%	112,769 $3.25 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $279,022 - $326,149	-8,695 Reduced 7.02%	115,199 $3.82 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $26,223 - $30,339	726 Added 0.59%	123,894 $4.54 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $74,959 - $97,585	1,903 Added 1.57%	123,168 $5.03 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $97,903 - $127,802	-2,345 Reduced 1.9%	121,265 $6.22 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $56,712 - $69,232	1,296 Added 1.06%	123,610 $5.41 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $75,378 - $89,375	-1,620 Reduced 1.31%	122,314 $6.41 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $28,090 - $34,807	-614 Reduced 0.49%	123,934 $6.42 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $253,580 - $375,891	-6,137 Reduced 4.7%	124,548 $7.35 Million
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $253,672 - $325,864	-6,463 Reduced 4.71%	130,685 $5.62 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $6,715 - $7,607	187 Added 0.14%	137,148 $5.37 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $248,763 - $280,555	-7,428 Reduced 5.14%	136,961 $4.96 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $125,746 - $159,897	3,757 Added 2.67%	144,389 $5.32 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $65,881 - $77,293	-2,075 Reduced 1.45%	140,632 $5.16 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $13,855 - $16,808	-460 Reduced 0.32%	142,707 $4.67 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $192,453 - $274,974	-7,120 Reduced 4.74%	143,167 $4.67 Million
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $183,430 - $208,169	-5,572 Reduced 3.58%	150,287 $5.89 Million
Q3 2019 Nov 04, 2019	SELL	$32.49 - $42.13 $1.17 Million - $1.52 Million	-36,062 Reduced 18.79%	155,859 $5.6 Million
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $268,105 - $301,020	-7,250 Reduced 3.64%	191,921 $8.31 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $450,300 - $494,729	-12,008 Reduced 5.69%	199,171 $8.46 Million
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $29,314 - $33,421	-762 Reduced 0.36%	211,179 $9.22 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $655,205 - $794,724	19,008 Added 9.85%	211,941 $9.34 Million
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $107,613 - $114,727	3,263 Added 1.72%	192,933 $7 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $70,297 - $81,555	2,203 Added 1.18%	189,670 $6.73 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $112,718 - $119,597	-3,389 Reduced 1.78%	187,467 $6.79 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $5.92 Million - $6.52 Million	190,856	190,856 $6.81 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Account

Montag A & Associates Inc Pfizer Inc Transaction History